This edition of the journal is devoted to the topic of cancer, and how leadership initiatives can improve the delivery of cancer services. Cancer is a challenging and complex disease, and reducing the burden of cancer requires incremental improvements across a broad spectrum, from prevention and healthy living to screening and early diagnosis, from treatment and post-treatment care, and from survivorship to palliative and end-of-life care. It is arguable that cancer outcomes can be improved by enacting effective cancer strategies, improving the availability of data, and changing how cancer services are delivered. Certainly many more cancers could be prevented, detected earlier, or treated better than currently are. Moreover, the quality of life for cancer survivors could be further improved, as could end-of-life and palliative care for those that require it.
A comprehensive discussion of all elements required to improve cancer outcomes is beyond the scope of this journal, instead, we focus on describing some of the initiatives that have taken place in Canada that have helped to improve the cancer system, focusing on the leadership actions that were required to implement these initiatives.
Our first article by Simon Sutcliffe and John French summarizes the component parts that comprise an effective, jurisdiction-specific cancer control strategy or plan. The authors note that, where there is a general consensus about what is required to improve the cancer system, the greater challenge is in generating context-specific plans that recognize the challenges and realities of the environment in which the plan is to be implemented. The article describes some of the leadership required for effective cancer planning, including a good understanding of the underlying culture and environment, and the engagement of key stakeholders.
Data are an important element of cancer control. Without a robust understanding of general trends in age standardized incidence rates, as well as survival and mortality trends, it is impossible to effectively plan cancer services. The backbone of cancer data is the various cancer registries and, more importantly, the visionary leadership of those who led the development and improvement of those registries. Data requirements and handling have evolved dramatically over the years, and this evolution is described by Cathy MacKay and Maureen MacIntyre in our second article. Providing more than a historical perspective, the authors describe how leadership, from clinicians and those who work with the registries, is essential to improving the availability and the quality of cancer data. Noting the importance of a comprehensive and coordinated approach, the authors identify a number of areas by which registry data can be improved, leading to a greater ability to plan and evaluate cancer-related services on a population basis.
Remaining with the theme of data, an initiative that increased the availability of clinical data in the form of Patient Reported Outcomes (PROs), and the means by which PROs were used to improve care delivery, is described by Robert Olsen and team in our next article. The article describes how the systematic collection of PRO data and the subsequent analysis of the data led to a number of research and quality improvement initiatives that led to changes in practice. The article describes the implementation and change management strategies and challenges that were utilized and highlights the importance of engaging frontline clinical staff in the development of this work.
Systematically improving the quality-of-care delivery is an important concept in all of healthcare. The Canadian Partnership for Quality Radiotherapy (CPQR) has been successful in adopting a "grass roots" approach to improving the quality of radiotherapy services across Canada. By defining quality standards that are accepted by the community at large, and using these standards to inform accreditation standards, radiotherapy services have been improved nationally. Mike Milosovic and Erika Brown describe the work of the CPQR in our fourth article and also outline the leadership strategies and actions that were utilized to move the partnership forward and ensure success. The CPQR is an effective model for how health services can be improved. By engaging stakeholders, including senior leadership, healthcare providers and patients, and focusing on providing guidance rather than being prescriptive, the CPQR has successfully identified means to improve technical quality, defined best practices for program structures and patient engagement strategies and, in conjunction with Accreditation Canada and the Canadian Institute for Health Information, developed both new accreditation standards and a national incident reporting strategy.
In our next article, Terry Sullivan and John English describe the importance of surgery in the management of cancer. They note that 80% of patients with cancer require surgery at some point, for purposes such as diagnosis, staging, treatment, debulking, or palliation. Historically in Canada, surgical services were not organized in the same manner as radiation therapy or chemotherapy services that were generally provided at academic-based cancer centres. This resulted in a fragmented care model, with surgical oncology not always fully integrated within a multidiscipline care environment. Additionally, concerning variations in practice became evident. In their article, Sullivan and English describe how surgical oncology services were transformed in Ontario, using a combination of performance metrics and public reporting of data (using a wait time information system) to improve wait times, and physician engagement and the establishment of communities of practice to define and disseminate evidence-based guidelines for surgical oncology procedures. The improvement in metrics such as the percentage of positive margins after prostate surgery, as illustrated in the article, is dramatic and ultimately results in improved patient outcomes.
In our final article, Lynne Nakashima discusses the challenges related to chemotherapy delivery in Canada. Chemotherapy and associated modalities such as hormone therapy, stem cell transplant, and newer treatment options including immunotherapy, targeted therapy, and personalized (or precision) medicine, are improving patient outcomes but are challenging to implement. Nakashima describes a number of pan-Canadian initiatives that are in place to evaluate the efficacy on new drugs and ensure a countrywide drug price negotiation strategy. Combined, these initiatives help ensure a more standardized availability of medications across the country and help ensure system sustainability for all through effective price negotiation strategies. These strategies will be critical in managing the health system in the future, considering projected increases in cancer incidence, and demonstrate how we are more effective working together.
I thank all the authors for contributing to this edition of the journal and hope that the readers find the articles useful.
